Shanhaidan Pharmaceutical

Xi'an Shanhaidan Pharmaceutical Group is a prominent Chinese pharmaceutical company specializing in the research, development, and manufacturing of cardiovascular medications, particularly those rooted in Traditional Chinese Medicine (TCM). The company is best known for its flagship product, Shanhaidan Capsules, which are widely used in China for treating coronary heart disease and angina. Beyond cardiovascular health, the group produces a variety of treatments for respiratory, digestive, and gynecological conditions. Shanhaidan operates modern GMP-certified manufacturing facilities and maintains a significant presence in the domestic Chinese market. It is a key subsidiary of the Shaanxi Pharmaceutical Holding Group.